ANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 3 STUDY TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF VACCINATION WITH EXPEC9V IN THE PREVENTION OF INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE IN ADULTS AGED 60 YEARS AND OLDER WITH A HISTORY OF URINARY TRACT INFECTION IN THE PAST 2 YEARS

Registry ID

VAC52416BAC3001

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

JANSSEN RESEARCH AND DEVELOPMENT LLC

Start date

2022-09-06

Last update

2021-09-23

Conditions

• URINARY TRACT INFECTION

Related clinical trials

• ANTIBIOTIC PROPHYLAXIS TO PREVENT POST-PROCEDURE UTI AFTER VCUG (APPRUV)
• PROPHYLACTIC ANTIBIOTICS FOLLOWING TREATMENT OF NEUROGENIC OVERACTIVE BLADDER WITH INTRADETRUSOR ONABOTULINUMTOXINA FOR THE REDUCTION OF POSTOPERATIVE UTI: A RANDOMIZED BLINDED PLACEBO-CONTROLLED TRIAL
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER, PROSPECTIVE STUDY TO ASSESS THE EFFICACY AND SAFETY OF ERAVACYCLINE COMPARED WITH LEVOFLOXACIN IN COMPLICATED URINARY TRACT INFECTIONS
• A RANDOMIZED CONTROLLED TRIAL ASSESSING THE EFFICACY OF ANTIMICROBIAL PROPHYLAXIS FOR EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (SWL) ON REDUCING URINARY TRACT INFECTION.

View on source registry